1. Home
  2. AQMS vs SNGX Comparison

AQMS vs SNGX Comparison

Compare AQMS & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$2.00

Market Cap

10.0M

Sector

Industrials

ML Signal

HOLD

Logo Soligenix Inc.

SNGX

Soligenix Inc.

SELL

Current Price

$0.35

Market Cap

8.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AQMS
SNGX
Founded
2014
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
8.2M
IPO Year
2015
2006

Fundamental Metrics

Financial Performance
Metric
AQMS
SNGX
Price
$2.00
$0.35
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $5.00
N/A
AVG Volume (30 Days)
33.5K
★ 208.9K
Earning Date
11-11-2026
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.03
EPS
N/A
★ N/A
Revenue
★ $2,100,000.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
$600.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.96
$0.28
52 Week High
$39.37
$1.76

Technical Indicators

Market Signals
Indicator
AQMS
SNGX
Relative Strength Index (RSI) 33.51 34.93
Support Level N/A $0.28
Resistance Level $2.98 $0.41
Average True Range (ATR) 0.16 0.01
MACD -0.04 -0.00
Stochastic Oscillator 10.98 11.11

Price Performance

Historical Comparison
AQMS
SNGX

About AQMS Aqua Metals Inc.

Aqua Metals Inc is developing and seeking to commercialize proprietary recycling and refining technologies for the recovery of critical minerals and metals. Its patented and patent-pending AquaRefining process is an electro-hydrometallurgical method designed to recover high-purity materials from battery and other metal-bearing feedstocks using a closed-loop system powered by electricity. Its idea is to reduce CAPEX and OPEX costs, reduce emissions, hazardous waste, and reliance on conventional smelting and chemical-intensive refining processes. It has one operating segment: sustainable metals recycling. It focused on the development and commercialization of AquaRefining technology for the clean and efficient recovery of valuable metals from lead-acid and lithium-ion batteries.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: